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A  basic,  fundamental  feature of an  antigen-stimulated  antibody response is the 
specificity of the binding capacity of the  antibodies  produced  for determinants  on 
that stimulating antigen. The exquisite specificity that is evidenced by antibodies for 
their  antigenic  determinants  is  also  observed  in  T  cell-mediated  killing  responses 
directed against cell surface antigenic molecules. The major target molecules for such 
cytotoxic T  effector cells are associated with the major histocompatibility complex 
(MHC) 1, which is the H-2 complex in the mouse. Although "cross-reactive" killing of 
cellular  targets  obtained  from  mice  with  different  H-2  haplotypes  is  frequently 
observed, recent evidence suggests that such cross-reactivity arises through the acti- 
vation of distinct prekiller cell clones. Although the majority of the cell clones reactive 
to  MHC  antigens  recognize the  immunodominant  specificity that  is distinct  for a 
given haplotype ("private" specificity), other distinct prekiller cell clones are specific 
for MHC  determinants  that  are shared  by a  number of different  H-2 haplotypes 
("public"  specificities)  (1-4).  Thus,  the  development  of cytolytic  effector T  cells 
directed against cell surface H-2 antigenic determinants appears to follow the laws of 
clonal selection and immunological specificity. Similar rules concerning the generation 
of antigen-specific help for T  cytolytic effector cell development have not been readily 
evident. T  cell help for alloreactivity can be generated with virtually any H-2I-region 
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difference (5). Such help is not specific for the prekiller T  cell clones that respond to 
either the H-2K and/or H-2D  region cytotoxic T  cell targeted specificities. Thus, 
nonspecific help provides an adequate signal for specific prekiller cell differentiation. 
Alloantigen-specific helper T  cells have been suggested, however, as a requirement 
for the generation of both antibody responses and of cytotoxic T  cells  derived from 
thymocyte precursors (6, 7). Alloantigen-specific helper T cells in both of these studies 
were obtained from mixed lymphocyte culture reactions (MLR). Long-term primed 
MLR cells were also demonstrated (8) to be capable of releasing materials that upon 
transfer into athymic nude mice could specifically help antibody responses to antigens 
of the  MLR-stimulating H-2  haplotype.  These  latter  findings have  not  yet  been 
confirmed or extended. In general, soluble help derived from short-term MLR culture 
supernatants has lead to the demonstration of nonspecific helper effects for both T 
and B effector cell development  (9-13).  Cloned antigen-specific helper T  cell lines 
derived from MLR cultures or, for that matter, any antigenic stimulus, all produce 
nonspecific soluble help in vitro. We also have not been successful in generating MHC 
antigen-specific soluble help in  vitro even when we have used either of the above 
short- or long-term culture procedures where MHC antigen-specific helper cells have 
been defined. Such overwhelming evidence for the production of nonspecific soluble 
helper factors has led to a  generalized belief that antigen-specific helper cells, upon 
contact with that antigen, do not release antigen-specific helper molecules. Rather, 
they release, amongst a  variety of factors, helper molecules that are not specific for 
that antigen but also help responses to other antigens in a bystander type effect (14- 
16). 
Most studies demonstrating nonspecific helper factor production have been per- 
formed in vitro; thus, we sought to investigate the possibility of generating MHC 
antigen-specific soluble help in vivo during the development of immune responses to 
skin allografts. The kinetics of factor production by cells in the lymph nodes draining 
the sites of the skin allotransplants were evaluated, and the dynamics of the response 
proved to be most interesting. MHC antigen-specific soluble help for the generation 
of cytotoxic effector T cells was evident as a relatively early event in the development 
of the immune response. The specificity of the soluble helper activity maps to the 
classical  MHC  regions,  whose  molecular  products  serve  as  targets  of effector  T 
mechanisms both in vivo and in vitro. In the strain combination chosen for our study, 
both  helper and  effector targets  mapped  to  the  H-2D  region.  The early phase  of 
antigen-specific soluble help was followed by an intermediate phase, during which we 
found lower levels of helper activity and preliminary evidence for the production of 
suppressor activity. The antigen specificity and/or targets of suppressive activity have 
not yet been identified. This intermediate phase was followed by a  second phase of 
helper factor production that proceeded through graft rejection before waning. The 
helper activity detected during this second later phase contained largely cross-reactive 
help, nonspecific help, and interleukin 2 (IL-2) activity. We describe the dynamics of 
factor production by cells within lymph nodes draining the sites of skin transplants 
and examine in detail the antigenic specificities for which the early phase skin graft- 
induced helper factor supernatants (SgHF) can provide help. 
Materials and Methods 
Animals.  The B10.A(18R) mice  (18R) were raised  locally (Rush-Presbyterian-St.  Luke's 
Medical Center, Chicago, IL) by strict brother-sister matings from breeding pairs provided by PLATE ET AL.  683 
Dr. Jack  Stimpfling, McLaughlin Research  Institute, Great  Falls, MT.  Dr.  Stimpfling also 
provided the B10.S(7R) mice (7R). The B6.TLa  a and B6.H-2  °zt mice (ozl) were raised by Dr. 
Lorraine Flaherty, New York Department of Health, Albany, NY.  The B10.M,  B10.D2-H- 
2aml(DM1),  (B6  ×  DM2)F1,  and  BALB/c-H-2am2(DM2)  lines  were  raised  by  Dr.  Roger 
Melvold,  Northwestern  University Medical  Center,  Chicago,  IL.  The DBA/2J,  HTG/AoJ, 
B10.A(2R)SgSn,  B10.D2nSn,  B10.BRSgSn,  and  C57BL/10SnJ  (B10)  mice were  purchased 
from The Jackson Laboratory, Bar Harbor, ME. The H-2 genotypes of the recombinant and 
mutant strains are given in Table I. 
Generation of Helper Factor Supernatants.  Supernatants containing nonspecific helper  factor 
activity (HFS) were obtained from two-step mixed lymphocyte culture procedures, as described 
previously (10).  C57BL/10  responder strain lymph node cells  (LNC)  and  B10.D2  gamma- 
irradiated spleen cells or vice versa were generally used for nonspecific HFS production. The 
supernatants  containing SgHF  were  derived  from  6-h  cultures  containing cells  from  the 
recipient strains' draining lymph nodes plus an equal number of LNC  from the skin donor 
strain. C57BL/10 mice and the congenic recombinant line B10.A(18R) served as recipients and 
donors, respectively, in the allotransplantation studies (Table I). 
Skin Grafting.  Full thickness body or tail skin grafts were performed according to the method 
of Billingham and Medawar (17).  C57BL/10SnJ mice served as the recipients of B10.A(18R) 
skin. At 4, 6, 8, 10, 12, 14, 16, and 19 d after graft emplacement, the lymph nodes draining the 
graft  sites were  removed, teased  apart  with  tuberculin syringe needles, and resuspended in 
RPMI  1640 medium at a  concentration of 4  ×  106 cells/ml. Cell suspensions of B10.A(18R) 
lymph nodes were similarly prepared and an equal number was mixed with the recipient cells. 
The final cell suspensions (8 X  106 cells/ml) were incubated for 6 h  at 37°C in a  humidifed 
atmosphere of 5% CO2. The supernatants were thereafter removed, filtered through a 0.45 #m 
Millipore filter (Millipore Filter Corp., Bedford, MA), aliquoted, and stored at -70°C. 
Assessment of Helper Factor Activity.  C57BL/10  recipient strain LNC at  106 cells/mierowell 
served as responders. Nucleated splenic cells from the skin graft donor strain B 10.A(18R) served 
TABLE  I 
Major Histocompatibility Haplotypes of Target Specificities 
H-2 phenotypes*  Specificities in common with 
K  I  S  D,L  Qa-2  Qa-1/  B10.A(18R) and foreign to 
Tla  C57BL/10 
C57BL/10  b  b  h  b,b  a  b/-0a) 
B10.A(18R)  b  h  b  d,d  a  a/+(a) 
P815-X2  d  d  d  d,d  --  ?/-0a) 
B10.M  f  f  f  f,f  b  ?/+(d) 
B6.TIa  a  b  b  b  b,b  a  a/+(a) 
BI0.A(2R)  k  k/d  d  b,b  a  b/-(b) 
B10.BR  k  k  k  k,k  b  a/+(a) 
B6.H-2  °zt  b  b  b  k,k  b  b/-0a) 
B10.S(7R)  s  s  s  d,d  a  a/+(a) 
B10.D2-H-2  amt  d  d  d  dml,dml[[  ?  ?/-(b) 
BALB/c-H-2  am2  d  d  d  d,dm2  b  b/+(c) 
H-2D,L, Qa-I (?)~ 
None 
Qa- 1, Tla§ 
H-2K  k cross-reactive public an- 
tigens 
Qa-1, Tla§; K* and D  k cross-re- 
active public antigens 
None 
H-2D,L; Qa-1, Tla 
Depressed  quantities of D  pri- 
vate  antigen H-2.4.  Possibly 
some  L-molecule  associated 
determinants. 
H-2D  a 
* Taken from Klein et al. (20). 
~: Qa-1 may be detectable on P815-X2 tumor cells (R. Rich et al., personal communication). 
§ Although peripheral lymphoid cells normally do not express TLa determinants, they might have 
become reexpressed on blast cells. 
I[ The DM1 mutation apparently is quite complex and involved a segment of chromosome that affects 
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as the source of antigenic stimulus. Cytotoxic effector  T  cells were generated during a 4- or 5- 
day incubation period in culture with gamma-irradiated (2,000 rad from a laTCs source)  cells. 
To assay for exogenous soluble helper activity, the normal generation of such killer cells was 
prevented by glutaraldehyde fixation of the stimulating strain cells.  The concentration of 
glutaraldehyde required to effectively block the normal generation of killer cells and yet allow 
their  development in  the  presence  of exogenous  soluble help  varied  with  the  responder- 
stimulator strain combination. In the studies reported here, we used  10 ml of a 0.01, 0.02, or 
0.05%  glutaraldehyde solution (Eastman Kodak,  Rochester,  NY)  and fixed  the  nucleated 
splenic cells at 37°C for 3 min. The cell suspensions were then immediately diluted to 50 ml 
with  RPMI  1640 medium containing 10%  human serum  and washed  three  times before 
culturing at either 0.5 ×  106 or 0.1  ×  106 viable cells/microwell. The cells were cultured in a 
final volume of 0.2 ml of RPMI 1640 medium containing 10% human serum (heated at 56°C 
for 30 min), 50 mM Hepes buffer plus 50 #g L-arginine, 75 #g L-glutamine, 100 U penicillin  G, 
and 75 #g kanamycin sulfate per ml. 2-mercaptoethanol, 10  -4 M, was an absolute requirement 
in cultures with glutaraldehyde-fixed cells. SgHF MLR-induced nonspecific HFS were added 
at a final concentration of 20%. 5-10 replicate wells for each assessment were set up, such that 
sufficient cells could be obtained after 4 or 5 d in culture to titrate the yield of killer activity 
generated. 
Assessment of the Generation of Killer Cells.  The quantitation of killer cell activity obtained was 
evaluated directly for each helper factor sample assayed in culture. An identical number of 
cells was initially cultured in replicate wells with or without the exogenous source of helper 
activity. The pool of viable cells recovered from the replicate wells was resuspended in 0.45 ml. 
The killer cell activities obtained were determined directly by titrating each pool in duplicate 
beginning  with 0.1 ml of cell suspension. Numbers of recovered viable cells were counted with 
the remaining  0.05 ml. This direct method of assessment allows us to present actual percentages 
of specific 51Cr release rather than calculated cytolytic units generated per sample assayed for 
a comparison of cells incubated, for example, without HFS, with HFS, and with SgHF. 
DBA/2-derived, H-2a-bearing, P815-X2  mastocytoma and/or nucleated eoncanavalin A 
(Con-A; Sigma Chemical Co., St. Louis, MO)-induced blast cells were labeled with I00 #Ci of 
51Cr (New England Nuclear,  lmCi/ml) and washed in Dulbeceo's phosphate-buffered saline 
(Grand Island Biological Co., Grand Island, NY), containing 3% calf serum. The 51Cr-labeled 
target cells at 2.0 ×  10  ~ cells/well were added to titrations of the killer cells, incubated at 37°C 
for 4 h before 150 #1 of supernatant was removed and ~aCr released thereto counted in a gamma 
scintillation counter. 
Killer cell  activity within draining lymph nodes and spleens of skin graft  recipients was 
determined after a  16-h incubation period with 5iCr-labeled P815-X2 target cells. 
The  percent  specific  51Cr release  and  percent  enhanced 5~Cr release  were  calculated  as 
follows: 
percent specific 51Cr release _epm experimental  cpm spontaneous 
cpm total  cpm total 
cpm experimental -  cpm giutaraldehyde 
percent enhanced 5aCr release  = 
cpm total 
IL-2 Proliferation Assay.  The presence of IL-2 in our various helper factor supernatants was 
evaluated  by  their  ability to  support  the  proliferation of antigen-primed LNC  (18, 19). 
Ovalbumin (OVA) was emulsified in complete Freund's  adjuvant (CFA), and 100/11 containing 
100 #g OVA was injected subcutaneously at the base of the tail. Regional lymph nodes were 
removed 7 d later, and cell suspensions of 6 ×  106 cells/2-ml macrowell were restimulated in 
culture with 100 #g OVA for 4 d. The cells were then collected, washed, and resuspended at  1 
×  105 LNC/ml of complete medium. An equal volume of cell  suspension, 0.I  ml/well, was 
mixed with supernatant and  further cultured for  4  d.  The cells  were  labeled with  1 /~Ci 
[SH]thymidine  (Schwarz/Mann,  Orangeburg,  NY;  sp  act  of 6  mCi/ml)  for  18  h  before 
harvesting and counting. The data presented are an average of quadruplicate samples. The 
FS6-14.13 T cell hybridoma was a generous gift from Dr. P. Marrack et al., Denver, CO. PLATE  ET  AL.  685 
Results 
Kinetics of Cytolytic Effector  T Cell Development after Skin Allograft Transplantation.  The 
generation of cytolytic effector cells in vivo was  examined in  HTG mice who had 
received a  skin graft from B10.D2 strain donors. These recipients recognize B10.D2 
strain cell surface antigens of the H-2D region as well as non-MHC:-associated antigens 
(20).  Such  skin  allografts were rejected by  11  d  post-transplantation  (unpublished 
observations). The detection ofcytolytic effector cells followed the kinetic of skin graft 
rejection (Fig. 1). Peak cytolytic activity was attained after the time of graft rejection 
with cells obtained from either the draining lymph nodes or spleens. The development 
of cytolytic effector cells was  detected earlier and  for a  broader period of time in 
draining lymph nodes (Fig. 1, left) than in spleens (Fig.  1, right). Significant levels of 
killer cell activity were not evident in a 4-h SlCr release assay but increased after 6 h 
to maximum or total killing at 24 h  (Fig. 2). The killer cell activity observed at both 
13 and  15 d was mediated by T  cells, as all activity was eliminated after treatment 
with an anti-Thy-l.2 serum [(AKR X RF)F1 anti-C58] plus complement. 
Kinetics of Soluble Helper Factor Production after Skin Allograft Transplantation.  Because 
the development of cytolytic effector T cells to the H-2D a region-determined antigens 
was demonstrable during and after allograft rejection, we sought to determine whether 
soluble helper factor was also produced to these same cell surface antigens  during 
.priming in vivo. We were particularly interested in the possible production of antigen- 
specific helper molecules; thus, we chose a  congenic resistant  recipient-donor strain 
combination in which  the strains  differed only for classical  class  I  transplantation 
antigens and were identical for class II, [ region-encoded antigens. The H-2D region 
lends itself more readily for such an.analysis  than does the H-2K region because a 
greater number of I-D region recombinant lines are available for specificity studies 
than  are  K-I  region  recombinants.  The  B10.A(18R)  recombinant  and  one  of its 
parental  lines,  C57BL/10,  were selected  as  a  combination  that  would  meet  these 
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FIG.  1.  The  detection of cytolytic effector T  cells during skin  allograft  priming in  vivo.  Left, 
draining LNC (0); and right, nucleated splenic cells (A) from HTG recipients of B 10.D2 skin grafts 
were assayed at optimum ratios of LNC (200:1)  and splenocytes (50:1)  against SlCr-labeled H-2  a- 
bearing PS15-X2 target cells for 15.5-17 h. The data are expressed as average and ranges of the 
activities obtained from two recipients assayed at each time point. 686  HISTOCOMPATIBILITY ANTIGEN-SPECIFIC HELPER  MOLECULES 
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Flo.  2.  Kinetics of S]Cr release mediated by allograft-primed cytotoxic effector cells. Cells from 6 
HTG recipients:  left, draining lymph nodes at 200:1 (m), 100:1 (A), and 50:1 (9)); and right, spleens 
at  100:1 (&), 50:1 (Q),  and  25:1 (IN) were assayed  against  P815-X2  target  cells  (A)  13  d  after 
receiving B 10.D2 skin allografts.  5~Cr release in mixtures of P815-X2  cells with LNC and nucleated 
splenocytes from nongrafted HTG recipients coincided with spontaneous release at 6 h and 9 h and 
an average increase of 3.8 and 4.5% at  18 h and 24 h, respectively. 
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Flo.  3.  Helper  activity of SgHF for  B10.A(18R) priming of C57BL/10 cytotoxic  eKector cell 
generation. The soluble  helper activities were obtained from 6-h cultures of C57BL/10 draining 
LNC at the various days (D) indicated after allotransplants of B10.A(18R)  skin or MLR in vitro 
(Co). The supernatants were assayed at a final concentration of 20% (black bars) and  10% (striped 
bars).  Nonspecific  HFS (Co) and  gamma-irradiated  B10.A(18R)  cells served as positive  controls. 
~]Cr-labeled  P815-X2  tumor cells served as targets in these assays. 
criterion.  The  B10.A(18R)  line originated  as a  recombination  between  the  H-2 b and 
H-2 a genotypes and differs from the C57BL/10  strain in the H-2D-TLa  regions (Table 
I). B 10.A(18R)  strain  skin donated  to B 10 recipients was rejected at  ~  12.5  d. 
6-h supernatants  were prepared  from C57BL/10  recipient draining lymph nodes at 
various times after skin grafting.  These supernatants  were assayed  for helper activity 
using glutaraldehyde-fixed  cells as  helper-dependent  stimulators  of cytolytic effector 
cell  development.  Skin  allograft-induced  production  of  helper  factor  activity  was 
clearly  evident  as  early  as  4  d  after  transplantation  (Fig.  3),  when  the  B10.A(18R) 
skin  donor  strain  fixed  cells were  used  as  stimulators.  The  higher concentrations  of 
SgHF, in fact, suggested a  biphasic kinetic response  in helper factor production, with 
a  final  waning  period  ~  1 wk after  graft  rejection.  The  biphasic  kinetic  response  in PLATE ET AL.  687 
helper production was supported in antigen specificity studies with strains that express 
few or no antigenic determinants in common with those of the H-2Da,L  a molecules. 
Antigen Specificity of SgHF Produced at Various Times during Allografi Priming.  Aliquots 
of the C57B L/10 anti- B 10.A (18R)  (B 10 anti- 18R) SgHF obtained at the various time 
points  and  tested  with  18R-fixed  cells  were  then  assayed  for specificity of soluble 
helper activity with different donor strains. The B 10.M strain (H-2  t) was chosen as a 
primary specificity control because this strain bears no known cross-reactive or public 
specificities in common with the  18R strain D a region (Table I) (21).  Little evidence 
of helper activity for the B 10.M strain was demonstrated in the SgHF induced during 
the early phase of allograft priming (Fig. 4). Helper activity was consistently detected, 
however, in supernatants obtained after graft rejection. The level of helper activity in 
19d  SgHF  for  the  response  to  B10.M  strain  fixed  stimulators  approximated  that 
obtained in control cultures  (Co) incubated with nonspecific HFS genecated in vitro 
(Fig. 4). 
The B 10.A(2R) recombinant strain was used as a second specificity control. It bears 
cross-reactive public  antigens  of the  H-2K  k in  common  with  those  of the  H-2D  a- 
defined molecules (21). The most significant levels of soluble helper activity detected 
for the B 10.A(2R) strain fixed stimulator cells were observed during the second phase 
of helper factor production around  the time of graft rejection  (Fig.  5).  Little helper 
activity for B 10.A(2R)  was observed with SgHF obtained during the early inductive 
phase of B 10 anti-18R allograft priming. When cross-reactive public antigens of both 
the  K k and  D k molecules were  presented  by B10.BR  strain  fixed  stimulator  cells, 
however,  a  somewhat  higher  degree  of helper  activity  was  observed  in  the  early 
induced first-phase SgHF preparations (Fig. 6). Again, an intermediate phase of lower 
helper factor activity was observed. 
These  data  taken  together  suggest  that  upon  initial  18R  allograft  priming,  B10 
draining LNC release helper molecules that are specific for determinants expressed by 
the  H-2D-TLa region-encoded  molecules.  The  lack  of support  provided  by  early 
phase SgHF helper activities observed for B 10.M and B 10.A(2R), as contrasted with 
18R  stimulator  cells,  strongly  support  this  conclusion.  Furthermore,  the  responses 
observed with  early phase  SgHF  and  B10.BR  strain  stimulating  ceils  suggest  that 
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Fla. 4.  Helper activity of B10 anti-18R-induced SgHF for B10.M priming ofC57BL/10 cytotoxic 
effector cell generation. The various samples assayed were identical to those used in Fig. 3 (see 
legend to Fig. 3).  Nonspecific HFS (Co) and  gamma-irradiated B10.M cells served as positive 
controls. 5aCr-labeled B10.M blast cells served as targets for these assays. 688  HISTOCOMPATIBILITY ANTIGEN-SPECIFIC HELPER  MOLECULES 
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F[o. 5.  Helper activity of B10  anti-18R-induced  SgHF for B10.A(2R) priming of C57BL/10 
cytotoxic effector cell generation. The various samples assayed were identical to those used in Fig. 
3 (see legend to Fig. 3). Nonspecific HFS (Co) and gamma-irradiated B10.A(2R) ceils served as 
positive controls. SlCr-labeled B 10.A(2R) blast cells served as targets for these assays. 
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F[o. 6.  Helper activity of B10 anti-18R-induced SgHF for B 10.BR priming ofC57BL/10 cytotoxic 
effector cell generatiow. The various samples assayed were identical  to those used in Fig. 3 (see 
legend to Fig. 3). Nonspecific HFS (Co) and gamma-irradiated B10.BR cells served as positive 
controls. 51Cr-labeled  B 10.BR blast cells served as targets for these assays. 
besides the specificity for the private H-2Dd-region antigens, the helper molecules also 
have specificity for the public cross-reactive specificities, such as H-2.3 and H-2.49 or 
their cellular targeted equivalents  (21).  Because these public determinants are asso- 
ciated with both the K k and Dk-encoded molecules, the B10.BR strain would have a 
greater  number  of such  determinants  than  has  either  the  B10.A(2R)  or  B6.H-2  °zl 
strain  (21).  The  concentration  of determinants  on  cell  surfaces  may,  therefore,  be 
reflected in their immunogenicity or potential as cytolytic effector cell targets. 
Assessment  of MHC Region Cross-Reactivities  of B l O-Anti-18R-primed Cytotoxic Cells.  The 
cross-reactivity observed between the B10.BR strain K k and D k antigens and those of 
the 18R strain D d was corroborated in killer cell assays with C57BL/10 LNC sensitized 
against gamma-irradiated  18R spleen cells. Blast cells from the B10.BR,  B 10.A(2R), 
B6.TLa a strains, the B10.D2-H-2 dmt  mutant,  and  the  DBA/2  (H-2~)-derived P815- 
X2  mastocytoma  tumor  cells served  as SXCr-labeled target  cells to  assess specificity 
and  cross-reactivity  of  killing.  Several  conclusions  can  be  drawn  concerning  the 
antigenic targets of the B10  anti-18R  killer cells. First, the highest  degree of killing 
was  obtained  against the  H-2Da-bearing P815-X2  target  cells (Fig.  7).  Second, the PLATE  ET  AL.  689 
DM I mutant-derived cells were readily killed and thus must bear adequate numbers 
of determinants in common with  18R to serve as targets. Third, little killer activity 
was directed against the Qa- 1  a, TLa  a determinants, as evidenced by the data obtained 
from the B6. Tla  a recombinant (Fig 7). Fourth, a substantially greater degree of killing 
was observed when public, cross-reactive antigens were expressed by both the K k and 
D * molecules of the B 10.BR strains, as contrasted with only those of the K * molecules 
of the B10.A(2R) strain (Fig. 7). The latter data, therefore, coincide with the degree 
of cross-reactivity observed when SgHF was used to support the generation of killer 
cells with  B10.BR  vs.  B10.A(2R)  fixed stimulator  cells  (Figs.  5  and  6).  The  data 
presented  in  Figs.  3-7  suggest,  therefore,  (a)  that  the  early  phase  SgHF  contain 
antigen-specific helper activity specific for both private (H-2.4) and public (H-2.3,49) 
cross-reactive determinants  encoded within  the  H-2D  a  region;  (b)  that  the  target 
antigens are not encoded within the Qa-1, TLa region; and (c) that the second phase 
of skin  graft-induced  helper factor production is  somewhat  nonspecific in  nature. 
These conclusions were substantiated in further specificity studies as well as in assays 
for IL-2 activity. 
Genetic Mapping of the Antigenic Specificity of Early Phase SgHF.  Various H-2 recom- 
binant and mutant lines of mice and either 6- or 8-d SgHF were used in these studies 
(Table I). The Qa-2 and Qa-1 a, TLa  a regions were eliminated from consideration in 
these mapping studies, as the B10 and 18R lines do not differ at the Qa-2 region, and 
the Qa-1 a, TLa  a region determined antigens did not serve as targets for 18R primed 
B10 killer cells (B6.TLa  a data, Fig. 7). 
Recombinant Lines.  SgHF consistently supported the enhanced generation of killer 
cells with glutaraldehyde-treated cells from the 7R-stimulating donors (Fig. 8, right), 
whereas virtually no support of killer cell development was consistently observed with 
the ozl-stimulating cells (Fig. 8, center). Substantial support was provided by SgHF 
for  18R-stimulated killer cell generation  (Fig. 8, left). The B10.S(7R)  recombinant 
line bears  the  H-2Dd,  L a  molecules in  common with  the  18R  line.  The  B6.H-2  °zl 
recombinant line differs from the 18R donor and B10 recipient lines only in its Dk,L  k 
~  P815 
DM 1 
810. BR 
3G 
v 
~  2o 
BIO.AI2RI 
10  -o  B6.TLa II 
0  6.25  12.5  25  50 
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Fro.  7.  Cross-reactivities  and  target  specificities of C57BL/10  cytotoxic  effector cells primed  in 
vitro with B10.A(18R). The percent spontaneous 5XCr release after 4 h with each target was: I)815- 
X2,  10.8;  DM1,  13.2;  B10.BR,  11.4;  B10.A(2R),  15.0; and B6.TLa a, 13.5. 690  HISTOCOMPATIBILITY ANTIGEN-SPECIFIC HELPER MOLECULES 
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Fro.  8.  H-2 region specificity  of early phase, 8-d B10 anti-18R-induced SgHF. The enhancement 
of C57BL/10 cytotoxic  effector  cell generation was assessed  with giutaraldehyde-fixed  cells from the 
BI0.A(18R), B6.H-2  °zl, and BI0.S(7R) recombinant lines. Nonspecific HFS (H)  served as the 
positive control in  assays to evaluate the  effects of SgHF (A--A).  Glutaraldehyde-stimulated 
background responses (B'---I) were subtracted from 18R and ozl responses but not 7R, as each 
background assay point was not available for the latter. 
molecules. These data, therefore, support the earlier suggestion that we could, indeed 
obtain  antigen-specific soluble  helper activity during  H-2 antigen  priming by skin 
allografts. Furthermore, the antigen specificity of the soluble help can be mapped to 
the H-2D  a region. 
Mutant  Lines.  A  number of distinct  cell surface molecules result from the genetic 
information contained within  the H-2D region  (22-25).  Mice bearing mutations in 
the H-2D-region complex have been most instrumental in the description of these cell 
surface molecules. We undertook, therefore, studies with selected H-2D-region mutant 
lines of mice to further refine the antigenic specificity of our soluble SgHF activity. 
The B10.D2-H-2 '~1 (DM1)  and BALB/c-H-2  a'~ (DM2)  mutant lines were used for 
these studies  (Table I). The DM 1 mutant, apparently, is a  result of a  more complex 
mutation than initially perceived, but a  consistent  finding is that  the private H-2.4 
specificity is  expressed  in  substantially  lower concentrations  than  is  detectable  by 
serological means on the parental  B10.D2  line  (H-2  s)  (26-29).  Recent  studies  (28) 
suggest  that  the  DM1  mutant  also expresses lower levels of public  antigens within 
both the D and L molecules. The DM 1 mutant line, however, does contain sufficient 
D-region cell surface antigens to serve as a target for B 10 anti-18R generated cytotoxic 
effector cells  (Fig.  7).  The BALB/c-H-2  dm~ does not express the  H-2L  d  (or H-2R  d) 
defined specificities,  but  its H-2D  d molecule is  expressed in  normal  quantities  (23, 
25). 
Only minimum support for the generation of B 10 anti-DM 1 cytotoxic effector cells 
was observed with SgHF, as contrasted with the nonspecific HFS (Fig. 9 B) when the 
sensitized  cells  were  assayed on  the  H-2a-bearing PS15-X2  tumor cells.  The  same 
SgHF readily supported the development of effector cells when the B10  responders 
were  primed  with  18R-fixed  cells  (Fig.  9A).  In  contrast,  we  found  that  SgHF 
supported DM2-primed generation of killer cells when assayed against either DM2 or 
P815-X2 targets (Fig.  10A and C). We considered the possibility that SgHF support 
for priming by the  mutant  lines might  have been  MHC-I-region restricted  for the 
stimulating cell. Thus, the generation of cytotoxic effector cells supported by SgHF PLATE  ET  AL.  691 
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FIo.  9.  H-2  antigenic  specificity  of early  phase,  8-d  B10  anti-18R-induced  SgHF.  The  H-2 d- 
bearing PS15-X2 tumor cells served as target cells for thgse assays. Glutaraldehyde-fixed cells served 
as stimulators in C57BL/10  LNC cultures supplemented with medium alone (O), 20% 8-d SgHF 
(C)), or nonspecific HFS (&). 
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Ro.  10.  H-2D a antigenic specificity of early phase, 6-d B10 anti-18R-induced  SgHF.  Glutaral- 
dehyde-fixed cells from the DM2 line (A, C), the BALB/c parental line (B), and  (B6 ×  DM2)F1 
hybrids (D) served as stimulators ofC57BL/10 cytotoxic effector cell generation. The cultures were 
supplemented with fresh medium alone (0), 20% 6-d SgHF (O), or nonspecific HFS (A). 692  HISTOCOMPATIBILITY  ANTIGEN-SPECIFIC HELPER MOLECULES 
was compared with that supported by nonspeeific HFS upon priming with fixed cells 
from the parental lines as well. The cytotoxic effector cell activity generated with the 
DM2 was substantially greater than that observed upon addition of either SgHF or 
HFS to the BALB/c parental line (H-2  a)  (Fig.  10 B). Furthermore, being concerned 
with other possible restriction elements of the  DM2  stimulator  strain  because the 
BALB/c strain differs from B 10.A(18R) at many additional loci, we tested F1 hybrid 
fixed cells from a mating of C57BL/6 and DM2 (H-2b/H-2am~. SgHF again readily 
supported the enhanced generation of cytotoxic effector cells (Fig.  10D). SgHF also 
can support the generation of killer cells upon priming with the native H-2Da-bearing 
B10.D2 line. Both the DM1  mutant cells and P815-X2 can serve as targets for this 
killing activity (Fig.  11 A and C). Again, little eytotoxic effeetor cell generation was 
supported by SgHF with  DM 1 priming cells  (Fig.  11 B  and  D).  This  is  in  direct 
contrast with the support of helping activity provided by the nonspeeific HFS (Fig 
11 B and D). It should be noted that the mutational events giving rise to DM 1 might 
have resulted in new target specificities for cellular responses, particularly because the 
B10.D2  parental  line  rejects  DM1  skin  grafts  and  new  serologically  detectable 
determinants  have  been  found  (3,  28).  The  DM1  line  also  differs  from  the  B10 
responder line for the K a target antigens as well as the gain mutant specifieities. The 
fact that the SgHF provided little or no support for these new antigenic speeificities 
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Fro.  11.  H-2 antigenic specificity of  early phase, 8-d B 10 anti- 18R-induced SgHF. Glutaraldehyde- 
fixed B10.D2 or DMI  stimulators were cultured with C57BL/10  LNC  and supplemented with 
medium alone (O), 20% 8-d SgHF (O), or nonspeeific  HFS (A). Each set of cultures was assayed 
against both PS15-X2 and DM1 Con-A blast cells. PLATE ET AL.  693 
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FIc. 12.  Kinetics of IL-2 production after altograft priming in vivo. The ability of the various 
supernatants to maintain OVA-primed blast cell proliferation was assessed via  [aH]thymidine 
incorporation. 
or for those of the H-2K  a region presented by DMl-stimulating cells also attests to its 
antigenic specificity, particularly for the D a region antigens. 
These data, therefore, support the conclusion that skin allograft, priming results in 
the production of antigen-specific helper factor activity and, furthermore, map the 
specificity determinants on the H-2D  a molecule. The antigen specific helper factor 
activities are produced and most readily detected as such during the first, early phase 
of the response. The later or second phase of factor production is complicated by the 
production of nonspecific factors, including IL-2. 
Kinetics of IL-2 Production after Skin Allografi Priming.  IL-2-containing supernatants 
obtained  from  the  Con  A-inducible,  IL-2-producing T  cell  hybridoma  FS6-14.13 
served as the positive control in an OVA-specific blast cell proliferative assay (18,  19). 
C57BL/10 supernatants  obtained on the various days after allograft priming  (4D- 
19D),  after MLR sensitization  (HFS)  and  Con  A  activation  (Con-A TCGF), were 
added to 1 ×  104 blast cells. The ability of these supernatants to maintain proliferation 
of blast  cells was evaluated 4 d  later through their incorporation of [3H]thymidine. 
Nonspecific HFS, Con-A-induced TCGF  (IL-2), and  hybridoma produced IL-2 all 
supported OVA-primed blast cell proliferation (Fig. 12). IL-2 activity was not detected 
in the early 4-, 6-, and 8-d SgHF, but substantial  activity was detected in the  10-, 
12-, and 19-d SgHF. Thus, the kinetics of IL-2 secretion during allograft priming lend 
further support to our conclusions concerning the biphasic nature of helper produc- 
tion, with soluble antigen-specific helper activity release being an early phase event 
followed by the stimulation of nonspecific helper factors and IL-2 release. 
Discussion 
We  demonstrated  that  soluble  helper  molecules  specific  for  H-2  antigens  are 
produced during the development of immune responses to class I  MHC  molecules 
presented  by  skin  allotransplants.  The  H-2  antigen-specific  helper  molecules  are 
generated as a relatively early event during antigen priming. We suggest on the basis 
of our kinetic data that the production of H-2 antigen-specific helper molecules may 
precede  priming  of pre-effector cells.  The  antigen-specific  helper  molecules  plus 
antigen would subsequently trigger the effector  cell differentiation pathway(s). Neither 
the antigen alone nor the antigen-specific soluble helper molecules alone are sufficient 694  HISTOCOMPATIBILITY  ANTIGEN-SPECIFIC HELPER MOLECULES 
for the generation of cytotoxic effector cells in our assays in vitro. The clonal expansion 
or  continued  rapid  expansion  of these  primed  pre-effector  cells  may  be  further 
mediated by nonspecific helper factors or growth factors such as IL-2. The T  cells 
producing such nonspecific growth signals may be quite distinct from those producing 
the antigen-specific helper molecules or may represent a  different phase of T  helper 
cell  maturation.  The  differentiation of helper  T  cell  functions  was  particularly 
evidenced in our kinetic data, as we found nonspecific helper factor production at a 
later  phase  after  H-2-disparate  allograft  priming.  These  latter  phase  helper  or 
amplifier T  cells may eventually become memory cells. Thus, upon restimulation by 
appropriate antigen, such memory T  cells would release nonspecific helper factors. 
The production of nonspecific helper factors by cloned antigen-specific helper T 
ceils has been well documented (14-16). In fact, we suggest that the propagation of 
antigen-specific helper T  cell clones on the basis of growth dependence upon IL-2 
may result in the specific selection of memory cells rather than selection for primary 
helper cells.  If, indeed, it is  only the initially primed  helper T  cells that  produce 
antigen-specific  helper  factors,  it  might  be  quite  difficult  to  then  continuously 
propagate  such  cells  during this  early differentiation phase;  hence,  the  long-term 
differentiated clones  would  not  be  likely  to  produce  the  antigen-specific  helper 
molecules but would produce nonspecific factors, as has been observed (14-16). 
The existence of memory helper T  cells that produce predominantly nonspecific 
helper  factors  could  also  explain  the  ready detection  of nonspecific factors  after 
polyclonal activation of helper T  cells with H-2I-region differences in an MLR or 
with mitogens such as Con A. Our inability to detect antigen specificity of soluble 
help after MLR priming could be a result of such memory responses after Ia antigen 
triggering in  association with  foreign serum  borne  antigens in  the cultures  or  by 
syngeneic Ia triggering of an autologous T  cell response (30). MLR-derived superna- 
tants  would  then  contain  nonspecific  helper  or  amplifier  factors  that  mask  the 
detection of antigen-specific helper molecules. In fact, the identification of antigen- 
specific helper molecules within the myriad of factors produced after Con A stimu- 
lation has recently been documented (31).  Such polyclonal activation of memory T 
cells does not readily occur during skin alloantigen priming within draining lymph 
nodes. Thus, the identification of soluble antigen-specific helper molecules was greatly 
facilitated by the absence of other nonspecific factors. 
The specificity of the antigen-specific helper molecules induced by allograft priming 
maps to the H-2D a  molecules presented by the foreign tissue. The  SgHF is by no 
means monoclonal or monospecific in nature. The recipient's helper T ceils recognize 
multiple antigenic determinants on the H-2D  a molecules, including H-2.4, H-2.3, and 
H-2.49 (20, 21). The H-2.3 and H-2.49 antigens are cross-reactive or public specifici- 
ties,  and  evidence  for both  cytotoxic effector cells  and  later phase  helper  factors 
directed  against  such  determinants was  provided  by  the  B10.BR  and  B10.A(2R) 
strains.  The  genetic  mapping  of the  helper  specificity to  the  H-2D  a  region  was 
accomplished through the use of appropriate recombinant lines of mice such as the 
7R, ozl, and B6.TLa  a lines. The precise mapping to the H-2D a molecule, however, 
was accomplished with the DM 1 and DM2 mutant lines. These mutant lines bear the 
same H-2 haplotype for the H-2K  a through H-2S  a region and differ only in the H-2D 
region. Whereas minimal help was provided for responses to DM 1 strain cells by early 
phase SgHF, good support ofcytotoxic effector cell generation was provided for DM2 PLATE ET AL.  695 
strain cells. Several conclusions can be reached from these data.  (a) The early phase 
SgHF contains little or no nonspecific helper activity, as the SgHF did not support 
the generation of responses to the H-2K  a antigens presented by the DM 1 strain.  (b) 
Although  cellular  responses  can  be  generated  against  the  gain  or  new  antigenic 
specificities that resulted from the mutations within DM1, the B10 anti-18R SgHF 
again did not support the generation of significant levels of cytotoxic effector cells 
directed against these "unrelated" determinants. These findings further support the 
conclusions that little or no nonspecific help is provided by the early phase SgHF. (c) 
The  help  provided  to  DM2  strain  cells  in  contrast  to  DM1  precisely  maps  the 
molecular specificity of SgHF to antigenic determinants of the H-2D  a base molecule, 
as the DM2 lacks the H-2R and H-2L molecules (22-25). Thus, we can conclude that 
helper T  cell clones specific for class I MHC antigens do indeed exist and that at least 
one of their functional roles leads to the secretion of soluble antigen-specific helper 
molecules. The antigen-specific helper molecules in association with antigen provide 
a signal for the triggering of effector cell differentiation presumably in vivo as well as 
in vitro, as we have demonstrated. 
Summary 
Antigen-specific soluble helper molecules are produced during major histocompat- 
ibility complex-disparate allograft priming. Genetic mapping studies with appropriate 
recombinant and mutant  lines of mice have defined the antigen specificities of the 
soluble helper molecules described here as being directed against the H-2D  a molecules. 
The production of antigen-specific helper molecules is a relatively early event after H- 
2Dd-region allograft  priming.  A  later phase of factor production near the time of 
graft rejection also contains nonspecific helper factors and IL-2. 
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